These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8583558)

  • 1. Re: Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms.
    Frankel G
    J Urol; 1996 Mar; 155(3):1039. PubMed ID: 8583558
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms.
    Lepor H; Theune C
    J Urol; 1995 Jul; 154(1):116-8. PubMed ID: 7776406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.
    Low BY; Liong ML; Yuen KH; Chee C; Leong WS; Chong WL; Khan NA; Cheah PY; Liong KK
    J Urol; 2008 Apr; 179(4):1461-9. PubMed ID: 18295277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia.
    Boyle P; Robertson C; Manski R; Padley RJ; Roehrborn CG
    Urology; 2001 Nov; 58(5):717-22. PubMed ID: 11711348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.
    Mokhtari G; Shakiba M; Ghodsi S; Farzan A; Heidari Nejad S; Esmaeili S
    Urol Int; 2011; 87(1):19-22. PubMed ID: 21597261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
    Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
    J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
    Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
    Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of alpha1-adrenergic blockaders in voiding disorders in women].
    Sivkov AV; Romikh VV; Egorov AA
    Urologiia; 2002; (5 Suppl):52-63. PubMed ID: 12518672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
    Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H
    J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy].
    Suzuki Y; Katoh T; Isurugi K; Obara W; Omori S; Goto Y; Fujioka T; Numasato S
    Hinyokika Kiyo; 2001 Jan; 47(1):15-21. PubMed ID: 11235215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terazosin for benign prostatic hyperplasia.
    Wilt TJ; Howe RW; Rutks IR; MacDonald R
    Cochrane Database Syst Rev; 2002; (4):CD003851. PubMed ID: 12519611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terazosin vs finasteride for BPH.
    Zacks M
    J Fam Pract; 1996 Dec; 43(6):533. PubMed ID: 8969692
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.
    Lepor H; Auerbach S; Puras-Baez A; Narayan P; Soloway M; Lowe F; Moon T; Leifer G; Madsen P
    J Urol; 1992 Nov; 148(5):1467-74. PubMed ID: 1279214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy].
    Park YC; Nishioka T; Arai Y; Tomoyoshi T; Kurita T; Hayashida H; Nagai N; Inoue H; Kataoka K; Kitagawa Y
    Hinyokika Kiyo; 1992 Jul; 38(7):857-68. PubMed ID: 1381869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
    J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R; Hosmane B; Bonacci E; O'Dea R
    J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pressure and metabolic effects of terazosin in essential hypertension].
    Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
    Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial.
    Liu H; Liu P; Mao G; Chen G; Wang B; Qin X; Na Y; Liu Z; Wang X; Xu X
    Urology; 2009 Jul; 74(1):130-6. PubMed ID: 19371934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terazosin for hypertension.
    Med Lett Drugs Ther; 1987 Dec; 29(755):112-3. PubMed ID: 2891021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.